Quick hello — tell us who you are in the lab

• Which role best describes the person answering today? Options: Lab Director, Quality Manager, Laboratory IT Lead, Operations Manager, Analytical Scientist, Other
• What type of lab environment do you operate in? Options: Pharmaceutical (GMP), Biotech (GMP/GLP), Contract Testing/CRO, Environmental/Chemical, Academic/Other
• Which regulatory frameworks apply to your lab (select all that apply)? Options: 21 CFR Part 11, EU Annex 11, GLP, ISO/IEC 17025, None/Not regulated, Other
• What system are you primarily using today for sample tracking and test results? Options: Spreadsheets, Aging LIMS (in-house/custom), Commercial LIMS, Paper-based, Hybrid (mix)
• Roughly how many analysts and users would actively use a new LIMS day-to-day? Options: 1–5, 6–20, 21–50, 51–200, 200+
• How many unique tests or methods does the lab run (estimate)? Options: <20, 20–50, 51–200, 201–500, 500+

Is This Working — Or Just Barely Holding On?

• If an inspector asked why you still rely on spreadsheets or manual COA assembly, what would you say?
• Which of these problems causes the most operational pain today? Options: Lost or mis-identified samples, Manual COA creation/errors, Duplicate data entry across systems, Slow review/approval cycles, Instrument data not captured reliably, Other
• When those issues happen, how do they usually surface (e.g., delayed release, audit finding, rework)? Options: Delayed product release, Audit/inspection observation, Analyst rework, Customer complaint, We quietly cover it up
• Tell us about a recent example where the current process failed — what happened and what was the outcome?
• On a scale of feeling, how much stress or concern does your current system cause you or your team? Options: Constantly worried, Frequently concerned, Occasionally concerned, Seldom concerned
• How often do manual entry or integrity gaps lead to corrective actions or CAPAs? Options: Monthly, Quarterly, Annually, Never documented

The Instrument and Workflow Tangled Web

• What would it cost the business if your instruments stopped reliably talking to your data system tomorrow?
• Which instrument categories do you use in your lab (select all that apply)? Options: HPLC/UPLC, GC, Mass Spec, Spectrophotometers, pH/Conductivity, Dissolution, Automated samplers/robots, Other
• How many unique instrument models/vendors would need integration for a meaningful rollout? Options: 1–5, 6–15, 16–40, 40+
• Do you currently have any instrument integrations in place (direct, middleware, or manual export/import)? Options: Direct instrument-to-LIMS, Middleware (e.g., instrument gateway), Manual file exports/imports, No integrations
• Which data capture gaps worry you most — raw instrument files, result transcription, calibration records, or something else? Options: Raw file retention, Result transcription errors, Calibration & maintenance logs, Sample to instrument mapping, Other
• Describe a workflow where data flow breaks down today (e.g., sample registration → result capture → review). Where do you see the biggest handoffs?

Who Pulls the Strings — and Who Gets Blamed?

• If the LIMS project stalled, who in your organization would need to sign off on pausing it — and why?
• Which stakeholders should be actively involved in requirements and acceptance (select all that apply)? Options: Quality/QA, Laboratory Management, IT/Infrastructure, R&D/Scientists, Regulatory Affairs, Supply Chain/Operations, Vendors/Third-party
• Who will be the functional owner of the LIMS after deployment (day-to-day operations)? Options: Lab Director, Quality Manager, IT Team, Dedicated LIMS Administrator, Shared responsibility
• How do analysts and supervisors typically react to process changes — enthusiastic, skeptical, or somewhere in between? Options: Enthusiastic/adaptive, Cautiously optimistic, Skeptical/resistant, Actively resistant
• What past change or system rollout felt easiest or hardest — and what made the difference?
• Are there internal governance or change-control processes we should factor in (e.g., steering committee, CAB, IT change windows)? Options: Yes — formal steering/committees, Informal approvals, Ad-hoc decisions, None

Validation: The Necessary Headache — How Real Is It For You?

• If I told you a validated LIMS could cut inspection risk by a clear margin, would you believe it or want proof? Options: I believe it but want proof, I want full documentation, Not convinced yet
• What validation deliverables do you expect from a LIMS implementation (select all that apply)? Options: IQ/OQ/PQ protocols and reports, Traceability matrices, Validation master plan, Test scripts and evidence, CSV/21 CFR Part 11 compliance docs, Other
• Who will own or sign validation artifacts internally? Options: Quality/QA, Lab Director, IT, Validation Team, Vendor with joint sign-off
• Have you completed IQ/OQ/PQ for lab systems before? Tell us about one successful or difficult validation experience.
• What timeline and resource constraints should we know about for completing validation? Options: Aggressive (weeks), Moderate (1–3 months), Extended (3–6 months), Flexible/uncertain
• What would be an unacceptable validation risk for you — e.g., missing traceability, no electronic signatures, or unclear test coverage?

Success Signals — How Will You Know We’ve Won?

• What measurable outcomes would make this project a clear success for you and your executive team? Options: Reduced release time, Fewer data integrity findings, Reduced manual entry hours, Faster sample-to-COA turnaround, Improved audit readiness, Other
• What specific KPI baseline can you share today (e.g., average days from test complete to COA, manual hours per week)?
• What percentage improvement in those KPIs would you consider a meaningful win in 6–12 months? Options: 10%, 20–30%, 30–50%, 50%+
• Beyond metrics, what qualitative outcomes would make you feel the project succeeded (e.g., less analyst frustration, fewer inspection nerves)?
• Who in your organization will be checking those success metrics after go-live? Options: Lab Leadership, Quality/QA, Operations, IT, Executive Sponsor
• How soon after deployment do you expect to see the first tangible improvement? Options: Immediately (within weeks), 1–3 months, 3–6 months, Longer than 6 months

Migration & Data: What’s Worth Bringing Forward?

• If you could only migrate three types of data from legacy systems, which would they be? Options: Sample history and IDs, Test results and calculations, Method definitions and SOP links, Audit trails, Calibration/maintenance records, Other
• What legacy sources hold the data you care about (select all that apply)? Options: Spreadsheets/CSV files, Old LIMS export, Paper records, Instrument files, ERP/Manufacturing systems, Other
• How much historical data must remain searchable for regulatory or business reasons? Options: Full history, Last 2–5 years, Last year, Only going forward
• Are there unique identifiers or sample naming conventions we must preserve to avoid breaking traceability? Options: Yes — strict IDs, Somewhat — loose conventions, No formal convention
• What are your biggest migration concerns — data loss, mapping complexity, timing, or analyst disruption? Options: Data loss, Field mapping complexity, Timing/downtime, Data quality/cleansing, Stakeholder alignment
• Do you have internal resources available for mapping and validation of migrated data, or would you expect vendor support? Options: Internal team available, Mixed internal + vendor, Vendor-led

Change, Adoption, and Reality Check

• If analysts had to change daily routines, what would alarm them most about a new LIMS? Options: More steps/ slower workflow, Loss of control over data, Complex logins/e-signatures, Reduced visibility into samples, Other
• How do you prefer to handle training and enablement — short hands-on sessions, train-the-trainer, or formal classroom certification? Options: Hands-on sessions, Train-the-trainer, Formal classroom, Self-paced e-learning, Combination
• Who would be your superusers or champions to help adoption on day one?
• How tolerant is your operation for a cutover weekend or short downtime window? Options: We can do weekend/downtime, Only brief windows (<2 hours), No downtime tolerated, Flexible with planning
• What contingency or rollback expectations would make stakeholders comfortable during cutover? Options: Full rollback plan, Parallel run period, Read-only legacy access, Formal sign-off gates
• What concerns do analysts voice most often when a new system is proposed (capture a quote if possible)?

Decision, Timing, and Practical Next Steps

• If everything aligned, when would you realistically want to begin an implementation project? Options: Immediately (within 1 month), Within 1–3 months, 3–6 months, 6+ months, Undecided
• Who ultimately controls budget approval for a project like this? Options: Lab Director, VP/Head of Operations, Finance, Procurement, Composite/Committee
• What are the top three risks that would stop this project from moving forward?
• Would you be open to a hands-on workshop where we model a few of your real sample scenarios in our system? Options: Yes — schedule workshop, Maybe — need more info, No
• What would be the ideal outcome of an initial discovery and workshop session for you? Options: Clear scope and timeline, Detailed validation plan, Preliminary ROI/benefit estimate, Executive summary for approvals, Other
• Please list any documents or artifacts we should request before that session (SOPs, sample data, instrument lists, inspection reports).

• Customer Workflow Confirmation
• Data Integrity & Compliance Mapping
• Hands‑On Solution Experience: Sample → Result → CoA (with Customer Data)
• Exception & Edge‑Case Workshop (Reconciliation, Overrides, Instrument Failures)

• Implement identified configuration changes in a test environment for PQ preparation.
• Select 2–4 real customer scenarios and obtain required artifacts for hands-on validation.
• Customer to deliver anonymized sample records, screenshots, and any error logs for selected scenarios.
• Facilitator to capture and circulate the one-sentence current and future state statements and a list of scenario owners.
• Schedule hands-on Solution Experience session(s) with required system access and test data.
• Recap Current State & Consequence
• Align on which regulatory/data integrity gaps the LIMS must close and why each is critical.
• Define clear, testable acceptance criteria and required validation evidence for each control.
• Agree owners for any policy/SOP updates needed to reflect the new controls.
• Produce a gap mapping document tying each pain point to the LIMS control and acceptance criterion.
• Customer to identify regulatory owner and share any prior inspection reports or regulatory constraints.
• Prepare a validation artifact checklist tailored to the agreed acceptance criteria.
• One‑Sentence Future State Recap
• Prove end-to-end that the LIMS produces the agreed future-state outcomes for the selected scenarios.
• Force customer validation at checkpoints so every claim is confirmed or corrected in-session.
• Capture any remaining configuration gaps and convert them into testable PQ scripts.
• Team to produce a session report mapping each proven step to the acceptance criteria and customer confirmations.
• Customer to approve the list of PQ scripts derived from the demonstrated scenarios.
• Introductions & Objectives
• Review Exceptions Identified Earlier
• Ensure every high-priority exception has a documented system behavior, business rule, and testable acceptance criterion.
• Assign owners for scripting and validation of exception cases in PQ.
• Agree notification/escalation policies to minimize operational downtime and inspection risk.
• Document exception flows with screenshots or step-by-step scripts and publish to the project traceability matrix.
• Create PQ test scripts for each agreed exception scenario and assign execution dates and owners.
• Configure notification rules in the test environment for verification during PQ.
• Agree and document a crystal-clear one-sentence current state for the workflows under review.
• Surface and quantify the operational and regulatory consequences tied to current failures.
• Regulatory Controls Overview
• Pre‑work Check & Data Load Verification
• State the Current One‑Sentence
• Simulate: Instrument Failure & Reconciliation
• Simulate: Result Override / Correction
• Walkthrough: Sample Scenario A (e.g., incoming raw material)
• Demonstration: Sample Registration & Barcode Flow
• Gap Mapping Exercise
• Simulate: Re‑test & Sample Merges/Splits
• Demonstration: Instrument Integration & Result Capture
• Walkthrough: Sample Scenario B (e.g., stability/timepoint workflow)
• LIMS Enforcement Patterns
• Define Notification & Escalation Rules
• Define Acceptance Criteria
• Demonstration: Result Review, Spec Check & E‑signature
• Identify Pain Points & Root Causes
• Validation & Audit Deliverables
• Quantify Consequences
• Demonstration: CoA Generation & Release
• Finalize Acceptance Tests for Each Exception
• Define Candidate Future State (one sentence)
• Validation Checkpoints & Forced Confirmation
• Next Steps & Scenario Selection for Proof
• Identify Gaps & Configuration Changes
• Agree Next Steps for PQ Scripts & Acceptance Testing

• Configure sample registration and barcode label templates
• Deploy barcode-driven sample tracking and scanner setup
• Configure test method library and calculation routines
• Integrate laboratory instruments for automated data capture
• Configure result entry, specification checks, and alerts
• Implement electronic review workflows and Part 11 signatures
• Generate and automate Certificates of Analysis (CoA)
• Configure stability study scheduling and reporting module
• Migrate legacy sample and result data into LIMS
• Execute IQ/OQ/PQ validation and deliver validation reports
• Configure role-based security and audit trail retention
• Train laboratory analysts and administrators on workflows

Configure sample registration and barcode label templates

• Should we include configuration of sample registration fields and barcode label templates in scope? Options: Yes, No
• Which sample identifier schema do you use or prefer (e.g., lab-defined accession, customer lot, combined)?
• How many distinct sample types or sample classes need unique registration templates? Options: 1-10, 11-50, 51-200, 200+
• Which mandatory metadata fields must be captured at registration (e.g., collection date, matrix, client PO, storage conditions)?
• What barcode label formats are required? Options: Tube labels, Rack/plate labels, Sheet/continuous labels, Custom size/format
• Are there external identifiers that must be accepted or mapped during registration (e.g., customer IDs, ERP order numbers)? Options: Yes, No

Deploy barcode-driven sample tracking and scanner setup

• Do you want barcode-driven tracking and scanner setup deployed as part of this project? Options: Yes, No
• How many physical locations (receiving, bench, storage, QC) will use barcode scanning? Options: 1, 2-3, 4-6, 7+
• Approximately how many scanners/readers are needed? Options: 1-5, 6-20, 21-50, 50+
• Which scanner types or interfaces do you plan to use? Options: Handheld USB, Bluetooth mobile, Fixed/automation, Imager/camera
• Do you require offline scanning capability (store-and-forward) for any locations? Options: Yes, No
• Where will label printing occur (e.g., receiving, bench, central print) and any constraints on label materials?

Configure test method library and calculation routines

• Should configuration of the test method library and calculation routines be included? Options: Yes, No
• How many test methods do you expect to import/configure initially? Options: 1-20, 21-100, 100+
• Do your methods require complex calculation logic (e.g., weighted averages, matrix corrections, multi-stage calculations)? Options: Yes, No
• Are methods standardized (e.g., USP, EP) or primarily lab-specific procedures? Options: Standard pharm methods (USP/EP), Lab-specific/custom
• Do you require SOP/version linkage, change control, and effective-dates for methods? Options: Yes, No
• Which roles will be responsible for maintaining the method library (e.g., QA, Lab Admin)? Options: Quality, Lab Administrator, Instrument Owner, Other

Integrate laboratory instruments for automated data capture

• Is instrument integration for automated data capture required in scope? Options: Yes, No
• Which instrument types/models do you plan to integrate initially? Options: HPLC, GC, LC-MS, UV-Vis, Balances, pH meters, Other
• How many individual instrument endpoints will be integrated? Options: 1-5, 6-20, 21+
• Do your instruments support standard drivers/APIs or will middleware/file-drop be required? Options: Standard drivers/API available, Middleware or instrument server required, File export/import only, Unknown
• What data formats do instruments produce that we must support (e.g., CSV, vendor binary, XML)? Options: CSV/TSV, XML, JSON, Vendor proprietary/binary, Other
• Who will own instrument-side configuration and qualification (customer, vendor, shared)? Options: Customer, Vendor, Shared

Configure result entry, specification checks, and alerts

• Do you need configuration of result entry screens, specification checks, and alert rules? Options: Yes, No
• What proportion of results are entered manually versus received from instruments? Options: Mostly manual, Mixed, Mostly automated
• How many different specification templates or acceptance criteria sets are required? Options: 1-50, 51-200, 200+
• Do you require conditional or tiered specification rules (e.g., different specs by client or matrix)? Options: Yes, No
• Which alerting channels should be configured for OOS/OOT or instrument failures? Options: Email, In-app notification, SMS, Third-party ticketing integration
• What are the acceptance criteria for a successful result-check configuration (e.g., % automated flagging accuracy)?

Implement electronic review workflows and Part 11 signatures

• Is implementation of electronic review workflows and 21 CFR Part 11 compliant signatures required? Options: Yes, No
• Do you require sequential, parallel, or conditional multi-level review workflows? Options: Sequential multi-level, Parallel reviewers, Single reviewer, Conditional routing
• How many distinct reviewer roles will need e-signature authority? Options: 1-3, 4-10, 10+
• Do you require identity proofing / SSO / MFA integration for signature authentication? Options: SAML/SSO with MFA, Local credentials with MFA, Local credentials without MFA, Other
• What regulatory or audit acceptance criteria must signatures and review trails meet?
• Should review rationales, comments, and sign-off reasons be mandatory fields? Options: Yes, No

Generate and automate Certificates of Analysis (CoA)

• Do you want CoA generation and automation included in scope? Options: Yes, No
• How many distinct CoA templates are required (per product, per customer, per test type)? Options: Single template, Multiple templates (per product), Per-customer templates, Other
• Should CoAs include automatically populated stability or trend data? Options: Yes, No
• What distribution methods are required for CoAs? Options: PDF email, Customer portal/API, Automated print, Other
• Are there mandatory regulatory statements, disclaimers, or formatting requirements to include on CoAs? Options: Yes, No
• What are the acceptance checks for CoA correctness prior to release?

Configure stability study scheduling and reporting module

• Do you require configuration of the stability study scheduling and reporting module? Options: Yes, No
• How many active stability programs will be managed initially? Options: 0, 1-5, 6-20, 20+
• What is the complexity of your sampling schedule (fixed intervals, conditional triggers, custom per product)? Options: Simple fixed intervals, Conditional/complex schedules, Custom per product
• Do you need integration with environmental chambers or automated samplers for timestamped measurements? Options: Yes, No
• Which stability reports or deliverables are required (e.g., interim, trend analysis, final report)? Options: Interim reports, Trend analysis, Final report, Custom reports
• What retention and archival policy should apply to stability datasets? Options: Same as sample data retention, Separate retention policy, Custom retention period

Migrate legacy sample and result data into LIMS

• Is legacy data migration into the LIMS required for this engagement? Options: Yes, No
• Which legacy data sources must be migrated? Options: Spreadsheets, Legacy LIMS, Instrument files, Paper records, ERP/other
• Approximately how many historical records (samples/results/files) need migration? Options: <10k, 10k-100k, 100k-1M, >1M
• What is the expected quality of legacy data (completeness, consistency)? Options: Good, Moderate, Poor
• Do you require transformation/mapping assistance and reconciliation reporting post-migration? Options: Yes, No
• Which historical fields or artifacts must be preserved (original timestamps, audit notes, raw instrument files)?

Execute IQ/OQ/PQ validation and deliver validation reports

• Should IQ/OQ/PQ execution and delivery of validation reports be included in scope? Options: Yes, No
• Which validation protocol template will you follow? Options: Customer template, Vendor template, Both, No template yet
• Which validation phases are required? Options: IQ, OQ, PQ
• Who will author, review, and approve protocols and final reports (customer, vendor, joint)? Options: Customer, Vendor, Joint
• Is a requirements traceability matrix (RTM) expected as part of validation deliverables? Options: Yes, No
• What timeline do you have for completing IQ/OQ/PQ activities? Options: 2-4 weeks, 1-3 months, 3+ months

• Statement of Work (SOW)
• Master Services Agreement (MSA)
• Order Form / Commercial Terms
• Validation & Responsibility Matrix
• Acceptance Criteria & Go/No‑Go
• Implementation Timeline & Milestones
• Governance, RACI & Meeting Cadence
• Data Migration & Retention Plan
• Instrument Integration & Access Agreement
• Security, Privacy & Data Processing Agreement (DPA)
• Service Level Agreement (SLA) & Support
• Change Control & Change Order Process
• Training & Enablement Plan
• Final Acceptance & Handover Sign‑off

• Success Review & Metrics Validation
• Lessons Learned Workshop
• Enhancement & Issue Triage Session
• Operational Support Handover & SLA Review
• Executive Value Review & Renewal / Expansion Planning

• Agree and document SLAs, RACI, monitoring, and escalation procedures.
• Review Open Tickets & New Requests
• Create a prioritized, time-bound backlog of enhancements and issues with owners.
• Agree on SLAs and escalation routes for production issues and enhancement requests.
• Clarify validation effort and regulatory impact for changes to be scheduled.
• Convert discussed items into tracked tickets with priority, owner, estimated effort, and validation notes.
• Publish the prioritized backlog and next delivery window to the shared channel.
• Set up recurring triage cadence and identify attendees for ongoing sessions.
• Schedule the first quarterly business review and define its agenda owner.
• Handover Artifacts Review
• Complete formal handover to operational support with all artifacts acknowledged.
• Welcome & Objectives
• Schedule the recurring operational/business review cadence (e.g., monthly/quarterly).
• Sign-off the handover checklist and attach to the project archive.
• Create support contact card and SLA document in the shared channel and ticketing system.
• Executive Summary of Outcomes & ROI
• Secure executive alignment on realized value and a recommended path for renewal or expansion.
• Identify and prioritize 1–3 expansion opportunities with estimated benefits.
• Agree on commercial timeline and owners to begin procurement or contract discussions.
• Prepare an ROI one-pager and executive summary for procurement and finance teams.
• Create a proposal timeline for renewal/expansion with named owners and next steps.
• Schedule a commercial follow-up meeting with procurement/legal to begin negotiations.
• Validate each success signal with documented evidence and determine acceptance status.
• Agree on remediation plan and owners for any unmet signals with dates for re-evaluation.
• Capture customer qualitative feedback to contextualize metrics and risk posture.
• Compile and share the evidence pack (reports, screenshots, audit logs, validation artifacts) for archived acceptance.
• Create remediation tickets for unmet signals with owners, acceptance criteria, and target dates.
• Record formal acceptance sign-off or conditional acceptance with next review date.
• Workshop Framing & Pre-work Review
• Document a prioritized set of lessons learned with clear owners and timelines.
• Agree on at least three process or configuration changes to reduce risk and improve future deployments.
• Ensure actionable knowledge transfer into runbooks, training, and onboarding materials.
• Publish the lessons learned report and update the project playbook/runbooks with agreed changes.
• Assign owners to each improvement with target completion dates and verification criteria.
• Schedule follow-up checkpoint to validate implementation of agreed process changes.
• Risk & Compliance Posture
• Timeline Walkthrough
• Clarify Business Impact and Acceptance Criteria
• Current State Summary
• Roles, Responsibilities & RACI
• Success Signal Review (metric-by-metric)
• Monitoring, Alerts & Incident Process
• Customer Voice & Use Cases
• Estimate Effort & Risk
• Keep / Start / Stop Exercise
• Gap & Exception Analysis
• Opportunities for Expansion
• SLA & Escalation Agreement
• Root Cause Deep-dive (top 2 issues)
• Prioritization & Roadmapping
• Commercial Next Steps
• Customer Experience & Qualitative Feedback
• Communication & SLA Agreement
• Consolidate Improvement Actions & Ownership
• Ongoing Governance & Review Cadence
• Acceptance Decision & Next Steps